From Bioblast
|
|
|
|
|
MitoGlobal first |
Mitochondrial Medicine 2019 Hinxton UK
| Hinxton UK, 2019 Dec 11-13. Mitochondrial Medicine - From disease mechanisms to therapeutic development |
Wellcome Genome Campus (2019-12-11) MitoGlobal
Abstract: Mitochondrial Medicine - From disease mechanisms to therapeutic development, Hinxton, Unite Kingdom, 2019
General information
- Mitochondrial disorders have emerged as a major cause of inherited human disease. The past decade has seen major advances in our understanding of their genetic basis and the underlying pathology, but these findings have yet to translate into new therapies.
- This conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine.
- Topics will include:
- Mitochondrial medicine: current landscape of therapeutic opportunities
- Pre-clinical mitochondrial disease models
- Translatable biomarkers of disease progression
- Seeking impact: outcome measure selection for translational and clinical research
- Non-drug therapies
- Advocating for mitochondrial medicine therapeutic development
- Topics will include:
Venue
- Wellcome Genome Campus
- Hinxton, Saffron Walden CB10 1SA, UK
Organizers
- Chinnery Patrick - University of Cambridge, UK
- Falk Marni - Children’s Hospital of Philadelphia, USA
- Mootha Vamsi - Harvard Medical School, USA
Programme
- » The detailed program is available here
Registration
- registere here
Labels:
2019, MitoGlobal
Listed under MitoGlobal Events.
